Page 32 | Certara

Video

Advancing Rare Disease Therapies: The Power of Regulatory Expertise

Bringing treatments to patients with rare diseases has long been one of the biggest challenges…

CertaraFebruary 26, 2025

Video

How Biosimulation is Transforming Rare Disease Drug Development

Developing therapeutics for rare diseases comes with unique challenges—small patient populations, high variability in treatment…

CertaraFebruary 26, 2025

Video

Gene Therapy: A Transformative Shift in Rare Disease Treatment

After decades of promise, gene therapy is finally starting to deliver on its potential—especially for…

CertaraFebruary 26, 2025

Video

Navigating Rare Disease Regulations: Challenges, Opportunities, and Innovative Solutions

Bringing life-changing therapies to rare disease patients requires expertise, innovation, and a deep understanding of…

CertaraFebruary 26, 2025

Press Release

Certara Reports Fourth Quarter 2024 Financial Results

February 26, 2025 Issues Full Year 2025 Financial Guidance RADNOR, PA – February 26, 2025 – Certara,…

CertaraFebruary 26, 2025

Video

Behind the Science: A Conversation with Lamia Sid-Otmane

CertaraFebruary 25, 2025

Publication

The Unrealized Potential of Advanced Modeling Methods to Inform Early Strategic Planning for Payer Reimbursement

This article explores the overlooked yet critical role of early strategic planning for payer reimbursement…

CertaraFebruary 25, 2025

Blog

Gain Nonclinical Drug Safety Insights with Real-Time Data Analysis

February 24, 2025 Efficient drug development relies on informed decision-making. For toxicologists, having timely access…

CertaraFebruary 24, 2025

Blog

The History of Pinnacle 21

February 21, 2025 It was late 2007. Mad Men was the hottest show on TV.…

CertaraFebruary 21, 2025

Fact Sheet

The Tools You Need to Accelerate Rare Disease Drug Development

CertaraFebruary 20, 2025

Advancing Rare Disease Therapies: The Power of Regulatory Expertise

How Biosimulation is Transforming Rare Disease Drug Development

Gene Therapy: A Transformative Shift in Rare Disease Treatment

Navigating Rare Disease Regulations: Challenges, Opportunities, and Innovative Solutions

Certara Reports Fourth Quarter 2024 Financial Results

Behind the Science: A Conversation with Lamia Sid-Otmane

The Unrealized Potential of Advanced Modeling Methods to Inform Early Strategic Planning for Payer Reimbursement

Gain Nonclinical Drug Safety Insights with Real-Time Data Analysis

The History of Pinnacle 21

The Tools You Need to Accelerate Rare Disease Drug Development

Newsletter sign up

Quick links

Solutions

Contact